2Roubenoff R.Gout and hyperuricemia[J].Rheum Dis Clin North Am,1990,16:539-550.
3Milionis HJ,Kakafika AI,Tsouli SG,et al.Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia[J].Am Heart J,2004,148:635-640.
4Fujimoto N,Mouri N,Iwata K,et al.A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinaseytype IV collagenase) using monoclonal antibodies[J].Clin Chim Acta,1993,22:91-103.
5Ueda Y,Imai K,Tsuchiya H,et al.Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion[J].Am J Pathol,1996,148:611-622.
6Athyros VG,Elisaf M,Papageorgiou AA,et al.Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease:a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study[J].Am J Kidney Dis,2004,43(4):589-599.
7Nagahama K,Iseki K,Inoue T,et al.Hyperuricemia and Cardiovascular Risk Factor Clustering in a Screened Cohort in Okinawa,Japan[J].Hypertens Res,2004,27:227-233.
8Altieri P,Brunelli C,Garibaldi S,et al.Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure[J].European Journal of Clinical Investigation,2003,33:648-656.
9Marin F,Roldan V,Climent V,et al.Matrix metalloproteinases in atrial fibrillation[J].J Am Coll Cardiol,2004,43(1):152.
10Inokubo Y,Hanada H,Ishizaka H,et al.Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome[J].Am Heart J,2001,141(2):211-217.
